Our Mission
To create accurate, affordable technologies powered by mass spectrometry & AI that will have transformative applications in diagnostics, fermentation, drug discovery, and product design.
Researcher-led. AI-powered. Clinically focused.
Clients and
Collaborators
Samples analyzed
with spectrometry
Datasets analyzed
with MSOne
Metabolites
identified
Publications &
Patents
Born out of IIT Bombay and rooted in scientific research, Clarity Bio Systems unlocks the information hidden in metabolites to drive innovation and deliver impactful real-world solutions.
Our multidisciplinary team of scientists and technologists converts high-dimensional metabolomics data into actionable, reproducible insights that advance your goals in precision medicine, fermentation, product innovation, and beyond.
To create accurate, affordable technologies powered by mass spectrometry & AI that will have transformative applications in diagnostics, fermentation, drug discovery, and product design.
Harnessing biological data to build impactful solutions for a healthier, more sustainable future.
To create accurate, affordable technologies powered by mass spectrometry & AI that will have transformative applications in diagnostics, fermentation, drug discovery, and product design.
Harnessing biological data to build impactful solutions for a healthier, more sustainable future.
2020
Clarity Bio Systems was launched out of Dr. Wangikar's research lab at the Department of Chemical Engineering, IIT Bombay, with a vision to simplify and accelerate the analysis of large metabolomics datasets. Powered by two decades of research experience in metabolomics, metabolic engineering, and 13C flux analysis, this laid the foundation for our mission to harness technology and AI for enabling next-generation diagnostics and domain-exclusive metabolomics.
2022
Clarity Bio received CSR support to expand the core research and development capabilities in metabolomics for healthcare applications. We put together a multi-disciplinary team with expertise across mass spectrometry, AI/ML, engineering, data analysis, and bioprocess technology.
2023
Clarity Bio introduced MSOne, our flagship AI-powered platform for untargeted metabolomics data analysis. This groundbreaking platform, combining preprocessing and statistical analysis on a cloud-based intuitive interface to deliver deep biological insights from mass spectrometry data.
2024
Clarity received a $350,000 grant from the Good Food Institute to support cultivated meat production and sustainable food innovation. We are developing a genome-scale metabolic model of chicken and applying it along with spent media analysis to optimize chicken cell cultivation.
2025 - Today
Clarity Bio expands its client base and impact across healthcare and biopharma, gaining recognition for scalable, data-driven metabolomics solutions in precision medicine and biomanufacturing.
Join our trailblazing team of innovators, where world-class mentorship and competitive rewards fuel your growth and open the door to a fulfilling, future-ready career.